Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin.
González Fernández S, Amador García Y, Boris Porras LG, Mojena Martínez L, Soler Porro LL, Pish Martí G, Fonseca Chon L, Estrada Guerra Y, Álvarez Blanco JM, Garabito Perdomo A, Santel Odio FB, Varona Vázquez LA, Ricardo Serrano YM, Chao González L, Avila Albuerne Y, Sánchez Valdés L, Viada González CE, Ramos Suzarte M, Saumell Nápoles Y.
González Fernández S, et al.
J Oncol. 2022 Sep 1;2022:4128946. doi: 10.1155/2022/4128946. eCollection 2022.
J Oncol. 2022.
PMID: 36090901
Free PMC article.
New diagnosed patients that received nimotuzumab concurrent with chemotherapy and radiotherapy reached a higher overall and progression-free survival and better quality of life than the rest of the patients. Trial registration is RPCEC00000215 (Cuban Registry of Clinical T …
New diagnosed patients that received nimotuzumab concurrent with chemotherapy and radiotherapy reached a higher overall and progression-free …